Search results
From IDWiki
Page title matches
- 107 bytes (11 words) - 22:07, 1 April 2023
Page text matches
- #REDIRECT [[Dolutegravir/lamivudine]]62 bytes (6 words) - 22:03, 1 April 2023
- **Triumeq (if HLA B5701 negative): dolutegravir, abacavir, and lamivudine **Truvada (tenofovir/TDF and emtricitabine) with either dolutegravir or raltegravir2 KB (244 words) - 11:10, 30 April 2021
- |[[raltegravir]], [[dolutegravir]], [[bictegravir]] |[[dolutegravir]]||DTG4 KB (495 words) - 08:32, 25 January 2024
- **[[Dolutegravir]]/[[abacavir]]/[[lamivudine]] (Triumeq), only for individuals who are HLA-B **[[Dolutegravir]] plus ([[emtricitabine]] or [[lamivudine]]) plus ([[tenofovir alafenamide]5 KB (635 words) - 22:07, 1 April 2023
- **[[Abacavir]]/[[lamivudine]] with BID [[dolutegravir]]1 KB (184 words) - 14:49, 5 January 2022
- **'''R263K''' confers resistance to [[dolutegravir]] | rowspan="7" |[[Dolutegravir]]5 KB (840 words) - 08:59, 22 October 2020
- ...ovir disoproxil fumarate]]/[[emtricitabine]] 300 mg/200 mg PO daily plus [[dolutegravir]] 50 mg PO daily4 KB (590 words) - 14:50, 5 July 2022
- | [[dolutegravir]] || DTG7 KB (760 words) - 10:12, 13 October 2019
- *Dolutegravir 50 mg 1 tablet po daily9 KB (1,337 words) - 13:58, 14 September 2020